Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm
NCT04026776Phase 1Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2020
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of allopurinol (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Proportion with salt sensitivity of blood pressure, Salt sensitivity index and 5 more. Started Sep 2020; status: completed.
02
Drugs
allopurinol
Beyond the preview
Go deeper on NCT04026776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04026776.